Literature DB >> 36266640

Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.

Yuepeng Zhang1, Yueli Tian2,3.   

Abstract

OBJECTIVE: The incidence of papillary thyroid cancer (PTC) concomitant with Hashimoto's thyroiditis (HT) is gradually increasing over the past decades. This study aims to identify differentially expressed lncRNAs between tumor tissues of PTC with or without HT and further to confer a better understanding of lncRNA-based competing endogenous RNA (ceRNA) network in PTC with HT.
METHODS: GSE138198 containing tissue mRNA data and GSE192560 containing lncRNA data were utilized to perform differentially expression analysis. The ceRNA network was constructed based on miRNA-mRNA interactions merging with lncRNA-microRNA interactions. Functional enrichment analysis and protein-protein interaction (PPI) analysis were performed. The mRNA levels of core genes in the PPI analysis in tumor tissues collected from 112 PTC patients including 35 cases coexistent with HT were determined by quantitative real-time polymerase chain reaction (qRT-PCR).
RESULTS: A total of 57 genes and 40 lncRNAs, with value of |log2 fold change (FC)|≥ 1 and the adjusted P-value < 0.05, were deemed as differentially expressed genes and lncRNAs between PTC with and without HT. The pathways most significantly enriched by differentially expressed genes between PTC with and without HT were viral protein interaction with cytokine and cytokine receptor and cytokine-cytokine receptor interaction. CXCL10, CXCL9, CCL5, FCGR3A, and CCR2 owned degree values not less than 10 were deemed as core genes differentially expressed between PTC with and without HT. A total of 76 pairs of lncRNA-miRNA-mRNA ceRNA were obtained. Results of qRT-PCR partially demonstrated the bioinformatics results that the mRNA levels of CXCL10, CXCL9, CCL5, and CCR2 were remarkably elevated in tumor tissues collected from PTC patients coexistent with HT than those without HT (P < 0.001).
CONCLUSION: Our study offers a better understanding of the lncRNA-related ceRNA network involved in PTC with HT, providing novel key genes associated with PTC coexistent with HT.
© 2022. The Author(s).

Entities:  

Keywords:  Hashimoto’s thyroiditis; Papillary thyroid cancer; ceRNA; lncRNA; microRNA

Mesh:

Substances:

Year:  2022        PMID: 36266640      PMCID: PMC9583512          DOI: 10.1186/s12902-022-01173-6

Source DB:  PubMed          Journal:  BMC Endocr Disord        ISSN: 1472-6823            Impact factor:   3.263


  47 in total

1.  Duplications on human chromosome 22 reveal a novel Ret Finger Protein-like gene family with sense and endogenous antisense transcripts.

Authors:  E Seroussi; D Kedra; H Q Pan; M Peyrard; C Schwartz; P Scambler; D Donnai; B A Roe; J P Dumanski
Journal:  Genome Res       Date:  1999-09       Impact factor: 9.043

Review 2.  Autoimmune thyroid disorders.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Alda Corrado; Andrea Di Domenicantonio; Poupak Fallahi
Journal:  Autoimmun Rev       Date:  2014-10-25       Impact factor: 9.754

3.  Cancer statistics, 2022.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2022-01-12       Impact factor: 508.702

4.  Advances in Thyroid Carcinoma.

Authors:  Iñigo Landa
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

5.  Mast cell marker gene signature in head and neck squamous cell carcinoma.

Authors:  Zhimou Cai; Bingjie Tang; Lin Chen; Wenbin Lei
Journal:  BMC Cancer       Date:  2022-05-24       Impact factor: 4.638

Review 6.  The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma.

Authors:  Roberto Vita; Antonio Ieni; Giovanni Tuccari; Salvatore Benvenga
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

7.  Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.

Authors:  Oksana Sulaieva; Olena Chernenko; Oleksiy Selesnov; Oleksandr Nechay; Oleksandr Maievskyi; Tetyana Falalyeyeva; Nazarii Kobyliak; Olena Tsyryuk; Yurii Penchuk; Dmytro Shapochka
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

8.  Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies.

Authors:  Shinje Moon; Hye Soo Chung; Jae Myung Yu; Hyung Joon Yoo; Jung Hwan Park; Dong Sun Kim; Young Joo Park
Journal:  Endocrinol Metab (Seoul)       Date:  2018-12

9.  LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p.

Authors:  Kai Guo; Kai Qian; Yuan Shi; Tuanqi Sun; Zhuoying Wang
Journal:  Cell Death Dis       Date:  2021-11-22       Impact factor: 8.469

10.  Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.

Authors:  Siyuan Xu; Hui Huang; Jiaxin Qian; Yang Liu; Ying Huang; Xiaolei Wang; Shaoyan Liu; Zhengang Xu; Jie Liu
Journal:  JAMA Netw Open       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.